期刊文献+

妊娠期高血压疾病对围生儿的危害

Hazard of hypertensive disorder complicating pregnancy on perinatal infant
下载PDF
导出
摘要 妊娠期高血压疾病是一种常见的妊娠并发症,大约影响到5%~10%的孕妇,目前仍然是导致母婴死亡的主要原因之一。虽然一些极重度的妊娠期高血压疾病会随着胎儿胎盘的娩出而治愈,并不会对孕产妇产生明显的远期影响。但目前越来越多的证据显示,妊娠期高血压疾病对胎儿的影响不仅仅停留在胎儿期,可贯穿整个新生儿期,乃至延续到成人期。因此,在关注该病对孕产妇影响的同时,应高度重视其对围生儿的危害。该将综述妊娠期高血压疾病对围生儿的危害。 Hypertensive disorder complicating pregnancy is a common pregnancy complication, which involves in approximately 5% -10% of pregnant women. It is harmful to the pregnant woman and the fetus and still one of the leading causes of maternal and neonatal mortality. Although some pregnant women with very severe hypertensive disorder complicating pregnancy would cure with expulsion of fetus and the placenta and would poses significant long-term impacts on the pregnant woman, more and more evidences reveal that not only the impact of hypertensive disorder complicating pregnancy on the fetus is manifold, involving respiratory, circulatory, hematological, immune, nervous and endocrine systems ,but also the impact would not only exist in the fetal period but penetrate full neonatal period even stretch to adulthood. Therefore, at the same time of paying close attention to impacts on the pregnant woman herself of the disease, more attention should be paid to impacts of this disease on the perinatal infant. This paper reviewed hazard of hypertensive disorder complicating pregnancy on the perinatal infant.
作者 李然 封志纯
出处 《中国妇幼健康研究》 2009年第6期724-727,共4页 Chinese Journal of Woman and Child Health Research
关键词 妊娠 高血压 围生儿 围产期损害 pregnancy hypertension perinatal infant perinatal damage
  • 相关文献

参考文献10

  • 1Lowe S A, Brown M A, Dekker G A, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008 [J]. Aust N Z J Obstet Gynaecol,2009,49 (3) :242-246.
  • 2Kul M, Demirkaya E, Ipcioglu O M, et al. Perinatal risk factors affecting the maternal and fetal asymmetric dimethylarginine levels [ J]. Turk J Pediatr,2009,51 (2) : 141-145.
  • 3Pallotto E K, Kilbride H W. Perinatal outcome and later implications of intrauterine growth restriction [ J ]. Clin Obstet Gynecol, 2006,49 ( 2 ) : 257 -269.
  • 4Kirwin S M, Bhandari V, Dimatteo D, et al. Leptin enhances lung maturity in the fetal rat [ J ]. Pediatr Res ,2006 ,60 (2) :200-204.
  • 5Laivuori H, Gallaher M J, Collura L, et al. Relationships between mammal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia [ J ]. Mol Hum Reprod, 2006,12 ( 9 ) :551-556.
  • 6Gadzinowski J, Kowalska K, Vidyasagar D. Treatment of MAS with PPHN using combined therapy: SLL, bolus surfactant and iNO[ J]. J Perinatol,2008,28 ( Suppl 3 ) :56-66.
  • 7Gauster M, Moser G, Orendi K, et al. Factors involved in regulating trophoblast fusion : potential role in the development of preeclampsia [J]. Placenta,2009,30 ( Suppl A) :49-54.
  • 8Lawlor D A, Smith G D. Earlylife determinants of adult blood pressure [ J ]. Curr Olain Nelahrol Hypertens ,2005,14 ( 3 ) :259-264.
  • 9Cadden K A, Walsh S W. Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia[ J]. Hypertens Pregnancy, 2008,27(4) :396-405.
  • 10Hubel C A, WaUukat G, Wolf M, et al. Agonistic angiotensin Ⅱ type 1 receptor autoantibodies in postpartum women with a history of preeclampsia[ J ]. Hypertension, 2007,49 (3) :612-617.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部